Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Real-world experience of secukinumab treatment for ankylosing spondylitis at the Royal National Hospital for Rheumatic Diseases, Bath.

Williams T, Wadeley A, Bond D, Cavill C, Freeth M, Sengupta R.

Clin Rheumatol. 2020 Jan 27. doi: 10.1007/s10067-020-04944-5. [Epub ahead of print]

PMID:
31989323
2.

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: reply.

Yahya F, Gaffney K, Hamilton L, Lonsdale E, Leeder J, Brooksby A, Cavill C, Berry-Jenkins J, Boyle C, Bond D, Sengupta R.

Rheumatol Adv Pract. 2018 Oct 18;2(2):rky037. doi: 10.1093/rap/rky037. eCollection 2018. No abstract available.

3.

Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs.

McHugh N, Maguire Á, Handel I, Tillett W, Morris J, Hawkins N, Cavill C, Korendowych E, Mughal F.

J Rheumatol. 2019 Aug 15. pii: jrheum.190083. doi: 10.3899/jrheum.190083. [Epub ahead of print]

PMID:
31416922
4.

Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study.

Antony AS, Allard A, Rambojun A, Lovell CR, Shaddick G, Robinson G, Jadon DR, Holland R, Cavill C, Korendowych E, McHugh NJ, Tillett W.

J Rheumatol. 2019 Sep;46(9):1097-1102. doi: 10.3899/jrheum.180796. Epub 2019 Mar 1.

PMID:
30824637
5.

Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.

Allard A, Antony A, Shaddick G, Jadon DR, Cavill C, Robinson G, Korendowych E, McHugh N, Tillett W.

Rheumatology (Oxford). 2019 Feb 1;58(2):269-273. doi: 10.1093/rheumatology/key297.

PMID:
30247726
6.

Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.

Yahya F, Gaffney K, Hamilton L, Lonsdale E, Leeder J, Brooksby A, Cavill C, Berry-Jenkins J, Boyle C, Bond D, Sengupta R; for BRITSpA.

Rheumatology (Oxford). 2018 Apr 1;57(4):619-624. doi: 10.1093/rheumatology/kex457.

PMID:
29272541
7.

Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice.

Holland R, Tillett W, Korendowych E, Cavill C, Waldron N, Brooke M, McHugh NJ.

Ann Rheum Dis. 2018 Mar;77(3):343-347. doi: 10.1136/annrheumdis-2017-211996. Epub 2017 Nov 16.

PMID:
29146740
8.

Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study.

Espahbodi S, Bassett P, Cavill C, Freeth M, Hole J, Sengupta R.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):571-578. Epub 2017 Feb 24.

PMID:
28240589
9.

Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History.

Jadon DR, Shaddick G, Tillett W, Korendowych E, Robinson G, Waldron N, Cavill C, McHugh NJ.

J Rheumatol. 2015 Jul;42(7):1169-76. doi: 10.3899/jrheum.150083. Epub 2015 May 15.

PMID:
25979723
10.

Mortality in systemic sclerosis-a single centre study from the UK.

Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N.

Clin Rheumatol. 2013 Oct;32(10):1533-9. doi: 10.1007/s10067-013-2289-0. Epub 2013 Jun 29.

PMID:
23812618
11.

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis.

Tillett W, Jadon D, Shaddick G, Cavill C, Korendowych E, de Vries CS, McHugh N.

Ann Rheum Dis. 2013 Aug;72(8):1358-61. doi: 10.1136/annrheumdis-2012-202608. Epub 2013 Jan 3.

PMID:
23291384
12.

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis.

Jadon D, Tillett W, Wallis D, Cavill C, Bowes J, Waldron N, Dixon A, Sengupta R, Barton A, Korendowych E, McHugh NJ.

Rheumatology (Oxford). 2013 Feb;52(2):261-6. doi: 10.1093/rheumatology/kes254. Epub 2012 Oct 23.

PMID:
23093722
13.

Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.

Strickland G, Pauling J, Cavill C, McHugh N.

Clin Rheumatol. 2012 Aug;31(8):1215-22. doi: 10.1007/s10067-012-1997-1. Epub 2012 May 16.

PMID:
22588647
14.

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study.

Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh J, Korendowych E, McHugh N.

J Rheumatol. 2012 Jan;39(1):154-6. doi: 10.3899/jrheum.110845. Epub 2011 Nov 15.

PMID:
22089469
15.

Mortality in psoriatic arthritis - a single-center study from the UK.

Buckley C, Cavill C, Taylor G, Kay H, Waldron N, Korendowych E, McHugh N.

J Rheumatol. 2010 Oct;37(10):2141-4. doi: 10.3899/jrheum.100034. Epub 2010 Aug 3.

PMID:
20682670
16.

A modified Sharp score demonstrates disease progression in established psoriatic arthritis.

Ravindran J, Cavill C, Balakrishnan C, Jones SM, Korendowych E, McHugh NJ.

Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):86-91. doi: 10.1002/acr.20018.

17.

Primary nursing: steps towards the process.

Cavill CA, Johnson JM.

Nurs Times. 1981 Dec 2-8;77(49):2091-2. No abstract available.

PMID:
6915507

Supplemental Content

Loading ...
Support Center